合成路线1
该中间体在本合成路线中的序号:
(V) Alkylation of 5-hydroxyisoquinoline (I) with bromide (II) in DMF at 80 C afforded isoquinolinium salt (III). This was reduced to tetrahydroisoquinoline (IV) by catalytic hydrogenation in the presence of Pd/C. Finally, Mannich reaction with formaldehyde and perhydroazepine (V) in THF-water at r.t. provided the target compound.
【1】
Yuen, P.; Schelkun, R.M.; Szoke, B.; Tarczy-Hornoch K.; Synthesis and structure-activity relationship of substituted 1,2,3,4-tetrahydroisoquinolines as N-type calcium channel blockers. Bioorg Med Chem Lett 1998, 8, 18, 2415.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18668 |
5-isoquinolinol
|
2439-04-5 |
C9H7NO |
详情 | 详情
|
(II) |
18669 |
1-(4-bromo-1-phenylbutyl)benzene
|
|
C16H17Br |
详情 |
详情
|
(III) |
18670 |
2-(4,4-diphenylbutyl)-5-hydroxyisoquinolinium bromide
|
|
C25H24BrNO |
详情 |
详情
|
(IV) |
18671 |
2-(4,4-diphenylbutyl)-1,2,3,4-tetrahydro-5-isoquinolinol
|
|
C25H27NO |
详情 |
详情
|
(V) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(V) The esterification of 4,4-bis(4-hydroxyphenyl)pentanoic acid (I) with diazomethane in ethyl ether/methanol gives the methyl ester (II), which is treated with phenylmagnesium bromide in THF to yield 4,4-bis(4-hydroxyphenyl)-1,1-diphenyl-1-pentanol (III). The reduction of (III) with H2 over Pd/C in methanol affords 4,4-bis(4-hydroxyphenyl)-1,1-diphenylpentane (IV), which is finally condensed with azepane (V) and formaldehyde in hot ethanol/water.
【1】
Yuen, P.-w.; Malone, T.C.; Tarczy-Hornoch, K.; Rock, D.M.; Szoke, B.; Stoehr, S.; Schelkun, R.M.; Synthesis and biological activity of substituted bis-(4-hydroxyphenyl)methanes as N-type calcium channel blockers. Bioorg Med Chem Lett 1999, 9, 16, 2447. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
22391 |
4,4-bis(4-hydroxyphenyl)pentanoic acid
|
126-00-1 |
C17H18O4 |
详情 | 详情
|
(II) |
22392 |
methyl 4,4-bis(4-hydroxyphenyl)pentanoate
|
|
C18H20O4 |
详情 |
详情
|
(III) |
31669 |
4-[4-hydroxy-1-(4-hydroxyphenyl)-1-methyl-4,4-diphenylbutyl]phenol
|
|
C29H28O3 |
详情 |
详情
|
(IV) |
31670 |
4-[1-(4-hydroxyphenyl)-1-methyl-4,4-diphenylbutyl]phenol
|
|
C29H28O2 |
详情 |
详情
|
(V) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(XVII) The reaction of 4-hydroxybenzyl alcohol (V) with ethyl 2-bromoacetate (XI) by means of K2CO3 gives the phenoxyacetate (XII), which is then treated with SOCl2 in THF to obtain the benzyl chloride (XIII). Reaction of (XIII) with the indole derivative (VII) by means of NaH in DMF yields the adduct (XIV), whose ester group is reduced with LiAlH4 in THF to afford the 2-hydroxyethoxy compound (XV). Treatment of (XV) with CBr4 and PPh3 in THF provides the 2-bromoethoxy compound (XVI), which is converted into compound (XVIIII) by reaction with hexamethyleneimine (homopiperidine) (XVII) in THF. Finally, compound (XVIII) is debenzylated by hydrogenation with either H2 over Pd/C in ethanol/THF or with cyclohexadiene and Pd/C in THF/EtOH.
【1】
Miller, C.P.; Collini, M.D.; Tran, B.D.; et al.; Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens. J Med Chem 2001, 44, 11, 1654.
|
【2】
Harris, H.A.; Miller, C.P.; Komm, B.S.; Bazedoxifene Acetate. Drugs Fut 2002, 27, 2, 117.
|
【3】
Miller, C.P.; Tran, B.D.; Collini, M.D. (American Home Products Corp.); Estrogenic agents. EP 0802183; JP 1998036346; US 5998402 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
29474 |
4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol
4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol
|
623-05-2 |
C7H8O2 |
详情 | 详情
|
(VII) |
38490 |
5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole; benzyl 4-[5-(benzyloxy)-3-methyl-1H-indol-2-yl]phenyl ether
|
|
C29H25NO2 |
详情 |
详情
|
(XI) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(XII) |
51988 |
ethyl 2-[4-(hydroxymethyl)phenoxy]acetate
|
|
C11H14O4 |
详情 |
详情
|
(XIII) |
38491 |
ethyl 2-[4-(chloromethyl)phenoxy]acetate
|
|
C11H13ClO3 |
详情 |
详情
|
(XIV) |
38492 |
ethyl 2-[4-([5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indol-1-yl]methyl)phenoxy]acetate
|
|
C40H37NO5 |
详情 |
详情
|
(XV) |
38493 |
2-[4-([5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indol-1-yl]methyl)phenoxy]-1-ethanol
|
|
C38H35NO4 |
详情 |
详情
|
(XVI) |
38494 |
benzyl 4-[5-(benzyloxy)-1-[4-(2-bromoethoxy)benzyl]-3-methyl-1H-indol-2-yl]phenyl ether; 5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-1-[4-(2-bromoethoxy)benzyl]-3-methyl-1H-indole
|
|
C38H34BrNO3 |
详情 |
详情
|
(XVII) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
(XVIII) |
38495 |
1-[4-[2-(1-azepanyl)ethoxy]benzyl]-5-(benzyloxy)-2-[4-(benzyloxy)phenyl]-3-methyl-1H-indole; 4-[1-[4-[2-(1-azepanyl)ethoxy]benzyl]-5-(benzyloxy)-3-methyl-1H-indol-2-yl]phenyl benzyl ether
|
|
C44H46N2O3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) By condensation of N-(perhydroazepin-1-ylcarbonyl)-L-leucine (V) with 4-O-benzyl-L-tyrosine tert-butyl ester (VIII) by means of HOBT and diisopropylethylamine in DMF.
The two peptide intermediates (V) and (VIII) have been obtaines a follows:
L-Leucine fragment (V): The carbonatation of perhydroazepine (I) with CO2 and pyridine followed by reaction with SOCl2 gives perhydroazepin-1-ylcarbonyl chloride (II), which is condensed with L-leucine benzyl ester (III) yielding the N-acylated leucine ester (IV). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in THF to afford the target intermediate (V).
Tyrosine fragment (VIII): By esterification of 4-O-benzyl-L-tyrosine (VI) with isobutylene (VII) by means of sulfuric acid in dioxane.
【1】
Malone, T.; et al.; Identification and SAR studies of PD 151307, a novel N-type calcium channel blocker. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 122.
|
【2】
Roth, B.D.; Connor, D.T.; Malone, T.C.; Hamilton, H.W.; Rafferty, M.F.; Hu, L.-Y.; Cody, W.L.; He, J.X.; Nadasdi, L.; Brogley, L.; Urge, L.; Silva, D.F.; Song, Y.; Szoke, B.G.; Booth, R.J.; Lescosky, J. (Neurex Corp.; Pfizer Inc.); Peptidyl calcium channel blockers. US 6423689 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
(II) |
26713 |
1-azepanecarbonyl chloride
|
|
C7H12ClNO |
详情 |
详情
|
(III) |
22252 |
Benzyl (2S)-2-amino-4-methylpentanoate; Benzyl (S)-leucinate
|
|
C13H19NO2 |
详情 |
详情
|
(IV) |
26714 |
benzyl (2S)-2-[(1-azepanylcarbonyl)amino]-4-methylpentanoate
|
|
C20H30N2O3 |
详情 |
详情
|
(V) |
26715 |
(2S)-2-[(1-azepanylcarbonyl)amino]-4-methylpentanoic acid
|
|
C13H24N2O3 |
详情 |
详情
|
(VI) |
26716 |
(2S)-2-amino-3-[4-(benzyloxy)phenyl]propionic acid
|
16652-64-5 |
C16H17NO3 |
详情 | 详情
|
(VII) |
15926 |
2-methyl-1-propene; isobutylene
|
115-11-7 |
C4H8 |
详情 | 详情
|
(VIII) |
26717 |
tert-butyl (2S)-2-amino-3-[4-(benzyloxy)phenyl]propanoate
|
|
C20H25NO3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) Hexahydroazepine (I) was coupled with N-Boc-glycine (II) by means of EDC and HOBt, and the resulting amide (III) was reduced with LiAlH4 to give diamine (IV). Subsequent coupling of (IV) with 3,4-dichlorophenylacetic acid (V) in the presence of DCC afforded amide (VI). Finally, reduction of (VI) with aluminum hydride in THF provided the title compound.
【1】
de Costa, B.R.; et al.; Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: Structural requirements and binding affinity at the sigma receptor. J Med Chem 1992, 35, 1, 38.
|
【2】
De Costa, B.R.; Radesca, L.; Bowen, W.; Long, J.; Walker, J.M.; Rice, K.C.; Gray, N.M.; Contreras, P.C. (Pharmacia Corp.); N-(Arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamine derivs. for CNS disorders. EP 0518216; WO 9222279 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
(II) |
18066 |
N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid
|
4530-20-5 |
C7H13NO4 |
详情 | 详情
|
(III) |
30416 |
tert-butyl 2-(1-azepanyl)-2-oxoethylcarbamate
|
|
C13H24N2O3 |
详情 |
详情
|
(IV) |
30417 |
N-[2-(1-azepanyl)ethyl]-N-methylamine; 2-(1-azepanyl)-N-methyl-1-ethanamine
|
|
C9H20N2 |
详情 |
详情
|
(V) |
30414 |
2-(3,4-dichlorophenyl)acetic acid;2-(3,4-Dichlorophenyl)acetic acid |
5807-30-7 |
C8H6Cl2O2 |
详情 | 详情
|
(VI) |
30418 |
N-[2-(1-azepanyl)ethyl]-2-(3,4-dichlorophenyl)-N-methylacetamide
|
|
C17H24Cl2N2O |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(VII) The reaction of 2-chloro-5-nitroaniline (I) with NaNO2 in HCl and HOAc, followed by addition of CuCl2 and SO2 yields sulfonyl chloride (II). Reaction of (II) with NH4OH affords sulfonamide (III), which is then treated 3-methylaniline (IV) in 3-chlorotoluene to furnish intermediate (V). Final conversion of (V) into the target product is achieved by treatment in H2O/acetone with NaOH and carbamimidothioate (VIII), which can be obtained by reaction of dimethyl N-cyanodithioiminocarbonate (VI) with amine (VII) in EtOH.
【1】
Delarge, J.; Masereel, B.; Dogne, J.-M. (University of Liege); Benzenic sulphonamide derivs. and their uses. WO 0042004 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
43033 |
2-chloro-5-nitroaniline; 2-chloro-5-nitrophenylamine
|
6283-25-6 |
C6H5ClN2O2 |
详情 | 详情
|
(II) |
43034 |
2-chloro-5-nitrobenzenesulfonyl chloride;2-Chloro-5-nitro-benzenesulfonyl chloride;2-Chloro-5-nitrophenylsulfonyl chloride;6-Chloro-3-nitrobenzenesulfonyl chloride |
4533-95-3 |
C6H3Cl2NO4S |
详情 | 详情
|
(III) |
43035 |
2-chloro-5-nitrobenzenesulfonamide
|
96-72-0 |
C6H5ClN2O4S |
详情 | 详情
|
(IV) |
30687 |
3-methylphenylamine; m-toluidine
|
108-44-1 |
C7H9N |
详情 | 详情
|
(V) |
43036 |
5-nitro-2-(3-toluidino)benzenesulfonamide
|
|
C13H13N3O4S |
详情 |
详情
|
(VI) |
43037 |
[[bis(methylsulfanyl)methylene]amino]methane
|
|
C4H9NS2 |
详情 |
详情
|
(VII) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
(VIII) |
43038 |
methyl N-cyano-1-azepanecarbimidothioate
|
|
C9H15N3S |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(VI) The alkylation of 6-chloro-2-fluoropurine (I) with isopropanol (II) under Mitsunobu conditions gives 6-chloro-2-fluoro-9-isopropylpurine (III), which is regioselectively alkylated at the 6 position with 4-methoxybenzylamine (IV) to yield 2-fluoro-9-isopropyl-N6-(4-methoxybenzyl)adenine (V). Finally, the 2-fluoro position of (V) is aminated with perhydroazepine (VI) in n-butanol at high temperature in a sealed tube to afford the target trisubstituted purine.
【1】
Verdugo, D.E.; et al.; Discovery of estrogen sulfotransferase inhibitors from a purine library screen. J Med Chem 2001, 44, 17, 2683.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51672 |
6-chloro-2-fluoro-9H-purine
|
|
C5H2ClFN4 |
详情 |
详情
|
(II) |
19250 |
2-propanol
|
67-63-0 |
C3H8O |
详情 | 详情
|
(III) |
51673 |
6-chloro-2-fluoro-9-isopropyl-9H-purine
|
|
C8H8ClFN4 |
详情 |
详情
|
(IV) |
15098 |
4-Methoxybenzylamine; (4-Methoxyphenyl)methanamine
|
2393-23-9 |
C8H11NO |
详情 | 详情
|
(V) |
51674 |
N-(2-fluoro-9-isopropyl-9H-purin-6-yl)-N-(4-methoxybenzyl)amine; 2-fluoro-9-isopropyl-N-(4-methoxybenzyl)-9H-purin-6-amine
|
|
C16H18FN5O |
详情 |
详情
|
(VI) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The cuprous chloride-catalyzed Mannich reaction between propargyl alcohol (I), hexahydroazepine (II) and formaldehyde furnished aminobutynol (III), which was further converted to the corresponding chloride (IV) upon treatment with SOCl2. The title compound was then synthesized by alkylation of the anion of 9-benzylfluorene (V) with chloride (IV) in DMSO.
【1】
Roxburgh, C.J.; et al.; Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca2+-activated K+ permeability of erythrocytes. J Med Chem 2001, 44, 20, 3244.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16664 |
Propargyl Alcohol; 2-propyn-1-ol
|
107-19-7 |
C3H4O |
详情 | 详情
|
(II) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
(III) |
51109 |
4-(1-azepanyl)-2-butyn-1-ol
|
|
C10H17NO |
详情 |
详情
|
(IV) |
51110 |
1-(4-chloro-2-butynyl)azepane
|
|
C10H16ClN |
详情 |
详情
|
(V) |
51111 |
9-Benzylfluorene
|
1572-46-9 |
C20H16 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(IV) The reaction of 1,3-benzodioxol-5-ylmethylamine (I) with acryloyl chloride (II) by means of TEA gives the acrylamide (III), which is reductocondensed with perhydroazepine (IV) by means of LiAlH4 or BH3/THF in THF to yield the secondary amine (V). Finally this compound is condensed with 5-chloro-3-(3,5-difluorophenyl)isoxazole (VI) by means of BuLi in diethyl ether to afford the target tertiary amine.
The intermediate 5-chloro-3-(3,5-difluorophenyl)isoxazole (VI) has been obtained by two related ways: The condensation of 3.5-difluorobenzoyl chloride (VII) with malonic acid monoethyl ester (VIII) by means of BuLi gives 2-(3,5-difluorobenzoyl)acetic acid ethyl ester (IX), which is cyclized with hydroxylamine in HOAc to yield 3-(3,5-difluorophenyl)isoxazol-5-ol (X). Finally this compound is treated with POCl3 to afford the desired 5-chloro-3-(3,5-difluorophenyl)isoxazole (VI) intermediate.
Alternatively, the reaction of 3,5-difluoroacetophenone (XI) with diethyl carbonate (XII) by means of NaH yields also the already reported intermediate 2-(3,5-difluorobenzoyl)acetic acid ethyl ester (IX)
【1】
Nantermet, P.G.; et al.; Discovery of a nonpeptide small molecule antagonist of the human platelet thrombin receptor (PAR-1). Bioorg Med Chem Lett 2002, 12, 3, 319.
|
【2】
Freidinger, R.M.; Selnick, H.G.; Connolly, T.; Barrow, J.C.; Nantermet, P.G. (Merck & Co., Inc.); Isoxazole thrombin receptor antagonists. GB 2356198 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
33669 |
1,3-benzodioxol-5-ylmethylamine; 1,3-benzodioxol-5-ylmethanamine; 3,4-Methylendioxybenzylamine
|
2620-50-0 |
C8H9NO2 |
详情 | 详情
|
(II) |
11577 |
Acryloyl chloride; Acrylyl chloride;2-Propenoyl chloride |
814-68-6 |
C3H3ClO |
详情 | 详情
|
(III) |
56910 |
N-(1,3-benzodioxol-5-ylmethyl)acrylamide
|
|
C11H11NO3 |
详情 |
详情
|
(IV) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
(V) |
56911 |
3-(1-azepanyl)-N-(1,3-benzodioxol-5-ylmethyl)-1-propanamine; N-[3-(1-azepanyl)propyl]-N-(1,3-benzodioxol-5-ylmethyl)amine
|
|
C17H26N2O2 |
详情 |
详情
|
(VI) |
56912 |
5-chloro-3-(3,5-difluorophenyl)isoxazole
|
|
C9H4ClF2NO |
详情 |
详情
|
(VII) |
56913 |
3,5-Difluorobenzoyl chloride
|
129714-97-2 |
C7H3ClF2O |
详情 | 详情
|
(VIII) |
15086 |
3-ethoxy-3-oxopropionic acid
|
1071-46-1 |
C5H8O4 |
详情 | 详情
|
(IX) |
56914 |
ethyl 3-(3,5-difluorophenyl)-3-oxopropanoate
|
|
C11H10F2O3 |
详情 |
详情
|
(X) |
56915 |
3-(3,5-difluorophenyl)-5-isoxazolol
|
|
C9H5F2NO2 |
详情 |
详情
|
(XI) |
56916 |
3,5-Difluoroacetophenone
|
123577-99-1 |
C8H6F2O |
详情 | 详情
|
(XII) |
17470 |
diethyl carbonate; diethylcarbonate
|
105-58-8 |
C5H10O3 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(I)
【1】
Abe T. Pandey SK, Baba H. 2000. Electrochemical fluorination of hexahydroazepine, methylpiperidines and methyl l-hexahydroazepine-acetate: the preparation of F-(l-hexahydroazepine-acetyl fluoride) and its derivatives. J Fluor Chem, 105(1):149--157 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|